
First Bard Vein Filter Bellwether Heads to Jury
By Cara Salvatore Law360
Law360, Phoenix (March 29, 2018, 11:30 PM EDT) – a Phoenix federal jury began deliberations Thursdays in the first bellwether trial in multidistrict litigation over claims that device maker Bard’s clot-stopping vein implants splinted and migrated toward patients’ hearts after Bard closed its case by arguing evidence concerning predecessor implants and FDA warnings were red herrings . . .
Latest Posts
In Loving Memory
It is with profound sorrow that we announce the passing of Leo R. Beus. Leo was our beloved friend, partner, teacher and mentor. He has guided the firm...
In Loving Memory
Beus Gilbert McGroder Named In “Best Law Firms” (2023 Edition)
Beus Gilbert McGroder Phoenix lawyers recognized in Best Lawyers in America® (2023 Edition) Leo R. Beus - Recognized in Best Lawyers since...
Beus Gilbert McGroder Named In “Best Law Firms” (2023 Edition)
Patrick J. McGroder Named Top Trial Lawyer 2022 by Phoenix Magazine
Patrick J. McGroder III has contributed $50,000 to the University of Arizona Law's Advocacy program.